Mineralys Therapeutics Ownership | Who Owns Mineralys Therapeutics?
Mineralys Therapeutics Ownership Summary
Mineralys Therapeutics is owned by 57.96% institutional investors, 1.46% insiders, and 40.58% retail investors. Catalys pacific is the largest institutional shareholder, holding 11.20% of MLYS shares.
MLYS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Mineralys Therapeutics | 57.96% | 1.46% | 40.58% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Catalys pacific | 7.90M | 11.20% | $286.83M |
| Ra capital management | 7.32M | 11.19% | $277.72M |
| Samsara biocapital | 6.26M | 9.57% | $237.50M |
| Blackrock funding, inc. /de | 4.33M | 6.13% | $157.05M |
| Vanguard group | 3.35M | 4.75% | $121.68M |
| Caligan partners lp | 2.77M | 4.24% | $105.14M |
| Suvretta capital management | 2.13M | 3.26% | $80.85M |
| Fmr | 2.07M | 3.16% | $78.54M |
| Point72 asset management | 1.80M | 2.75% | $68.24M |
| Laurion capital management lp | 1.72M | 2.63% | $65.24M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Catalys pacific | 7.90M | 92.37% | $286.83M |
| Samsara biocapital | 6.26M | 31.01% | $237.50M |
| Caligan partners lp | 2.77M | 13.77% | $105.14M |
| Lion point capital, lp | 39.00K | 8.40% | $1.48M |
| Sr one capital management, lp | 1.56M | 8.03% | $56.76M |
| Velan capital investment management lp | 175.60K | 6.25% | $6.66M |
| 22nw, lp | 358.32K | 5.47% | $13.00M |
| Integral health asset management | 1.50M | 3.85% | $56.88M |
| Findell capital management | 250.00K | 3.74% | $9.48M |
| Ra capital management | 7.32M | 3.42% | $277.72M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 1.80M | 0.11% | 1.80M |
| Fmr | 2.07M | 0.00% | 1.77M |
| Farallon capital management | 1.67M | 0.26% | 1.67M |
| Holocene advisors, lp | 1.21M | 0.10% | 1.21M |
| Ra capital management | 7.32M | 3.42% | 1.18M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | - | - | -2.47M |
| Capital investors | 1.16M | 0.01% | -1.23M |
| Integral health asset management | 1.50M | 3.85% | -1.20M |
| Adams street partners | - | - | -1.13M |
| Catalys pacific | 7.90M | 92.37% | -1.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 1.80M | 0.11% | 1.80M | $68.24M |
| Farallon capital management | 1.67M | 0.26% | 1.67M | $63.44M |
| Holocene advisors, lp | 1.21M | 0.10% | 1.21M | $45.71M |
| Polar capital | 1.06M | 0.19% | 1.06M | $40.15M |
| Nationale-nederlanden powszechne towarzystwo emerytalne | 659.08K | 2.12% | 659.08K | $23.92M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -7.00 |
| Federated hermes | -21.00 |
| Signaturefd | -22.00 |
| Skopos labs | -26.00 |
| Golden state wealth management | -32.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 143 | -28.50% | 40,919,125 | -48.50% | 57 | 0.39% | 86 | -23.89% | 44 | -29.03% |
| Sep 30, 2025 | 193 | 15.57% | 76,304,723 | 16.16% | 116 | 1.16% | 109 | -9.17% | 59 | 118.52% |
| Jun 30, 2025 | 166 | 3.75% | 65,673,217 | 7.91% | 100 | 0.77% | 119 | 9.17% | 27 | -3.57% |
| Mar 31, 2025 | 159 | 48.60% | 60,569,327 | 31.79% | 113 | 1.35% | 107 | - | 28 | - |
| Dec 31, 2024 | 109 | - | 46,482,607 | - | 93 | - | 109 | - | - | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 09, 2026 | Rodman David Malcom | Chief Medical Officer | Sell | $58.27K |
| Feb 17, 2026 | Rodman David Malcom | Chief Medical Officer | Sell | $11.51K |
| Feb 12, 2026 | Rodman David Malcom | Chief Medical Officer | Sell | $168.63K |
| Feb 13, 2026 | Rodman David Malcom | Chief Medical Officer | Sell | $113.86K |
| Feb 12, 2026 | Rodman David Malcom | Chief Medical Officer | Sell | $15.44K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 18 |
| 2025 Q4 | - | 28 |
| 2025 Q3 | 2 | 10 |
| 2025 Q2 | - | 9 |
| 2025 Q1 | 3 | 3 |
MLYS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools